A prospective randomized controlled multicentre trial comparing half-dose photodynamic therapy (PDT) with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (CSC)
Latest Information Update: 25 Jul 2019
At a glance
- Drugs Verteporfin (Primary)
- Indications Central serous chorioretinopathy
- Focus Therapeutic Use
- Acronyms PLACE
Most Recent Events
- 25 Jul 2019 New trial record